Dennis Baltzis
About Dennis Baltzis
Dennis Baltzis serves as the President of Solstar Pharma, where he has worked since 2017. He has extensive experience in oncology and clinical research, having held positions at Covance, the Medical Research Council, and The Jewish General Hospital.
Current Role at SolStar Pharma
Dennis Baltzis serves as the President of SolStar Pharma, a position he has held since 2017. His leadership at SolStar Pharma is characterized by a focus on advancing pharmaceutical research and development. Under his guidance, the company aims to innovate within the pharmaceutical industry, particularly in areas related to oncology and hematology.
Previous Experience in Clinical Research
Prior to his current role, Baltzis worked at Covance as an Oncology Clinical Research Associate from 2015 to 2017 in the Montreal, Canada area. He also held the position of Senior Clinical Research Coordinator at The Jewish General Hospital from 2012 to 2015. His earlier experience includes serving as a Scientific Advisor at the Medical Research Council in Dundee, United Kingdom, from 2008 to 2011.
Educational Background
Dennis Baltzis completed his Ph.D. in Experimental Medicine at McGill University from 2002 to 2007. He also earned a Bachelor's Degree from McGill University, studying from 1999 to 2002. His academic background provides a strong foundation for his expertise in oncology, cancer research, and hematology.
Research and Scientific Expertise
Baltzis has a robust background in oncology and cancer research, complemented by his expertise in Good Clinical Practice (GCP) and molecular biology. His research experience includes a post-doctoral position at the MRC-Protein Phosphorylation Unit at the University of Dundee from 2008 to 2011, where he contributed to significant advancements in the field.